دورية أكاديمية

Respiratory Protection in a Time of Crisis: NIOSH Testing of International Respiratory Protective Devices for Emergency Use.

التفاصيل البيبلوغرافية
العنوان: Respiratory Protection in a Time of Crisis: NIOSH Testing of International Respiratory Protective Devices for Emergency Use.
المؤلفون: Andrews AS; Angela S. Andrews, MS, is a Physical Scientist; John R. Powers, Jr. is a Supervisory General Engineer; and Christopher C. Coffey, PhD, is the former Associate Director for Science (retired); all at the National Personal Protective Technology Laboratory (NPPTL), National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC), Morgantown, WV. Jaclyn K. Cichowicz, MA, and Marisa L. Fries are Health Communications Specialists; Patrick L. Yorio, PhD, is a Health Statistician; and Maryann M. D'Alessandro, PhD, is Director; all at the NPPTL, NIOSH, CDC, Pittsburgh, PA. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of NIOSH or CDC. Product and company names are provided for identification purposes only and do not imply endorsement by the CDC., Powers JR , Jr; Angela S. Andrews, MS, is a Physical Scientist; John R. Powers, Jr. is a Supervisory General Engineer; and Christopher C. Coffey, PhD, is the former Associate Director for Science (retired); all at the National Personal Protective Technology Laboratory (NPPTL), National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC), Morgantown, WV. Jaclyn K. Cichowicz, MA, and Marisa L. Fries are Health Communications Specialists; Patrick L. Yorio, PhD, is a Health Statistician; and Maryann M. D'Alessandro, PhD, is Director; all at the NPPTL, NIOSH, CDC, Pittsburgh, PA. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of NIOSH or CDC. Product and company names are provided for identification purposes only and do not imply endorsement by the CDC., Cichowicz JK; Angela S. Andrews, MS, is a Physical Scientist; John R. Powers, Jr. is a Supervisory General Engineer; and Christopher C. Coffey, PhD, is the former Associate Director for Science (retired); all at the National Personal Protective Technology Laboratory (NPPTL), National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC), Morgantown, WV. Jaclyn K. Cichowicz, MA, and Marisa L. Fries are Health Communications Specialists; Patrick L. Yorio, PhD, is a Health Statistician; and Maryann M. D'Alessandro, PhD, is Director; all at the NPPTL, NIOSH, CDC, Pittsburgh, PA. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of NIOSH or CDC. Product and company names are provided for identification purposes only and do not imply endorsement by the CDC., Coffey CC; Angela S. Andrews, MS, is a Physical Scientist; John R. Powers, Jr. is a Supervisory General Engineer; and Christopher C. Coffey, PhD, is the former Associate Director for Science (retired); all at the National Personal Protective Technology Laboratory (NPPTL), National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC), Morgantown, WV. Jaclyn K. Cichowicz, MA, and Marisa L. Fries are Health Communications Specialists; Patrick L. Yorio, PhD, is a Health Statistician; and Maryann M. D'Alessandro, PhD, is Director; all at the NPPTL, NIOSH, CDC, Pittsburgh, PA. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of NIOSH or CDC. Product and company names are provided for identification purposes only and do not imply endorsement by the CDC., Fries ML; Angela S. Andrews, MS, is a Physical Scientist; John R. Powers, Jr. is a Supervisory General Engineer; and Christopher C. Coffey, PhD, is the former Associate Director for Science (retired); all at the National Personal Protective Technology Laboratory (NPPTL), National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC), Morgantown, WV. Jaclyn K. Cichowicz, MA, and Marisa L. Fries are Health Communications Specialists; Patrick L. Yorio, PhD, is a Health Statistician; and Maryann M. D'Alessandro, PhD, is Director; all at the NPPTL, NIOSH, CDC, Pittsburgh, PA. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of NIOSH or CDC. Product and company names are provided for identification purposes only and do not imply endorsement by the CDC., Yorio PL; Angela S. Andrews, MS, is a Physical Scientist; John R. Powers, Jr. is a Supervisory General Engineer; and Christopher C. Coffey, PhD, is the former Associate Director for Science (retired); all at the National Personal Protective Technology Laboratory (NPPTL), National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC), Morgantown, WV. Jaclyn K. Cichowicz, MA, and Marisa L. Fries are Health Communications Specialists; Patrick L. Yorio, PhD, is a Health Statistician; and Maryann M. D'Alessandro, PhD, is Director; all at the NPPTL, NIOSH, CDC, Pittsburgh, PA. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of NIOSH or CDC. Product and company names are provided for identification purposes only and do not imply endorsement by the CDC., D'Alessandro MM; Angela S. Andrews, MS, is a Physical Scientist; John R. Powers, Jr. is a Supervisory General Engineer; and Christopher C. Coffey, PhD, is the former Associate Director for Science (retired); all at the National Personal Protective Technology Laboratory (NPPTL), National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC), Morgantown, WV. Jaclyn K. Cichowicz, MA, and Marisa L. Fries are Health Communications Specialists; Patrick L. Yorio, PhD, is a Health Statistician; and Maryann M. D'Alessandro, PhD, is Director; all at the NPPTL, NIOSH, CDC, Pittsburgh, PA. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of NIOSH or CDC. Product and company names are provided for identification purposes only and do not imply endorsement by the CDC.
المصدر: Health security [Health Secur] 2021 Jul-Aug; Vol. 19 (4), pp. 379-385. Date of Electronic Publication: 2021 Jan 11.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101654694 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2326-5108 (Electronic) Linking ISSN: 23265094 NLM ISO Abbreviation: Health Secur Subsets: MEDLINE
أسماء مطبوعة: Original Publication: New Rochelle, NY : Mary Ann Liebert, Inc., [2015]-
مواضيع طبية MeSH: COVID-19* , Public Health*, Environmental Health/*standards , Filtration/*standards , National Institute for Occupational Safety and Health, U.S./*standards , Respiratory Protective Devices/*standards, Filtration/instrumentation ; Humans ; Internationality ; Occupational Exposure/prevention & control ; United States
مستخلص: National Institute for Occupational Safety and Health (NIOSH)-approved respirators are required by the Occupational Safety and Health Administration (OSHA) when personal respiratory protection is used in US occupational settings. During the COVID-19 pandemic, the demand for NIOSH-approved N95 filtering facepiece respirators overwhelmed the available supply. To supplement the national inventory of N95 respirators, contingency and crisis capacity strategies were implemented and incorporated a component that endorsed the use of non-NIOSH-approved respiratory protective devices that conformed to select international standards. The development and execution of this strategy required the collaborative effort of numerous agencies. The Food and Drug Administration temporarily authorized non-NIOSH-approved international respiratory protective devices through an emergency use authorization, OSHA relaxed their enforcement guidance concerning their use in US workplaces, and NIOSH initiated a supplemental performance assessment process to verify the quality of international devices. NIOSH testing revealed that many of the non-NIOSH-approved respiratory protective devices had filtration efficiencies below 95% and substantial inconsistencies in filtration performance. This article reports the results of the NIOSH testing to date and discusses how it has contributed to continuous improvement of the crisis strategy of temporarily permitting the use of non-NIOSH-approved respirators in US occupational settings during the COVID-19 pandemic.
References: Clin Infect Dis. 2015 May 1;60 Suppl 1:S42-51. (PMID: 25878300)
Infect Control Hosp Epidemiol. 1995 Sep;16(9):529-31. (PMID: 8537633)
ACS Nano. 2020 May 26;14(5):6348-6356. (PMID: 32368894)
Disaster Med Public Health Prep. 2020 Oct;14(5):658-669. (PMID: 32423515)
Health Secur. 2019 Mar/Apr;17(2):152-155. (PMID: 31009256)
J Int Soc Respir Prot. 2020;37(1):52-60. (PMID: 32508390)
J Occup Environ Hyg. 2014;11(8):D115-28. (PMID: 24628658)
Health Secur. 2017 May/Jun;15(3):244-252. (PMID: 28636443)
معلومات مُعتمدة: CC999999 United States ImCDC Intramural CDC HHS
فهرسة مساهمة: Keywords: COVID-19; Epidemic management/response; National strategy/policy; Personal protective equipment; Public health preparedness/response
تواريخ الأحداث: Date Created: 20210112 Date Completed: 20210906 Latest Revision: 20220316
رمز التحديث: 20221213
مُعرف محوري في PubMed: PMC8906491
DOI: 10.1089/hs.2020.0173
PMID: 33434096
قاعدة البيانات: MEDLINE
الوصف
تدمد:2326-5108
DOI:10.1089/hs.2020.0173